Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways - PubMed (original) (raw)
. 2006 May 25;441(7092):537-41.
doi: 10.1038/nature04791.
Affiliations
- PMID: 16724069
- DOI: 10.1038/nature04791
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Dirk Grimm et al. Nature. 2006.
Abstract
RNA interference (RNAi) is a universal and evolutionarily conserved phenomenon of post-transcriptional gene silencing by means of sequence-specific mRNA degradation, triggered by small double-stranded RNAs. Because this mechanism can be efficiently induced in vivo by expressing target-complementary short hairpin RNA (shRNA) from non-viral and viral vectors, RNAi is attractive for functional genomics and human therapeutics. Here we systematically investigate the long-term effects of sustained high-level shRNA expression in livers of adult mice. Robust shRNA expression in all the hepatocytes after intravenous infusion was achieved with an optimized shRNA delivery vector based on duplex-DNA-containing adeno-associated virus type 8 (AAV8). An evaluation of 49 distinct AAV/shRNA vectors, unique in length and sequence and directed against six targets, showed that 36 resulted in dose-dependent liver injury, with 23 ultimately causing death. Morbidity was associated with the downregulation of liver-derived microRNAs (miRNAs), indicating possible competition of the latter with shRNAs for limiting cellular factors required for the processing of various small RNAs. In vitro and in vivo shRNA transfection studies implied that one such factor, shared by the shRNA/miRNA pathways and readily saturated, is the nuclear karyopherin exportin-5. Our findings have fundamental consequences for future RNAi-based strategies in animals and humans, because controlling intracellular shRNA expression levels will be imperative. However, the risk of oversaturating endogenous small RNA pathways can be minimized by optimizing shRNA dose and sequence, as exemplified here by our report of persistent and therapeutic RNAi against human hepatitis B virus in vivo.
Similar articles
- RNA interference inhibitors of hepatitis B virus.
McCaffrey AP. McCaffrey AP. Ann N Y Acad Sci. 2009 Sep;1175:15-23. doi: 10.1111/j.1749-6632.2009.04974.x. Ann N Y Acad Sci. 2009. PMID: 19796073 - Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
Cheng TL, Chang WT. Cheng TL, et al. Methods Mol Biol. 2007;408:223-41. doi: 10.1007/978-1-59745-547-3_13. Methods Mol Biol. 2007. PMID: 18314586 - Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver.
Grimm D, Wang L, Lee JS, Schürmann N, Gu S, Börner K, Storm TA, Kay MA. Grimm D, et al. J Clin Invest. 2010 Sep;120(9):3106-19. doi: 10.1172/JCI43565. Epub 2010 Aug 9. J Clin Invest. 2010. PMID: 20697157 Free PMC article. - miRNA cassettes in viral vectors: problems and solutions.
Liu YP, Berkhout B. Liu YP, et al. Biochim Biophys Acta. 2011 Nov-Dec;1809(11-12):732-45. doi: 10.1016/j.bbagrm.2011.05.014. Epub 2011 Jun 7. Biochim Biophys Acta. 2011. PMID: 21679781 Review. - RNA interference for studying the molecular basis of neuropsychiatric disorders.
Hoyer D. Hoyer D. Curr Opin Drug Discov Devel. 2007 Mar;10(2):122-9. Curr Opin Drug Discov Devel. 2007. PMID: 17436547 Review.
Cited by
- Systematic Comparison of CRISPR and shRNA Screens to Identify Essential Genes Using a Graph-Based Unsupervised Learning Model.
Ding Y, Denomy C, Freywald A, Pan Y, Vizeacoumar FJ, Vizeacoumar FS, Wu FX. Ding Y, et al. Cells. 2024 Oct 4;13(19):1653. doi: 10.3390/cells13191653. Cells. 2024. PMID: 39404416 Free PMC article. - LinQURE: A novel AAV gene silencing platform that supports multi-transcript targeting for complex disorders.
Bočkaj I, Moreno Garcia A, de Miguel Herraiz P, Keskin S, Zancanella V, Acar Broekmans Ş, Vallès A, Liu YP, Evers M, Wartel M. Bočkaj I, et al. Mol Ther Nucleic Acids. 2024 Aug 15;35(3):102307. doi: 10.1016/j.omtn.2024.102307. eCollection 2024 Sep 10. Mol Ther Nucleic Acids. 2024. PMID: 39290581 Free PMC article. - Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential.
Mazzuca C, Vitiello L, Travaglini S, Maurizi F, Finamore P, Santangelo S, Rigon A, Vadacca M, Angeletti S, Scarlata S. Mazzuca C, et al. Front Immunol. 2024 Aug 19;15:1443297. doi: 10.3389/fimmu.2024.1443297. eCollection 2024. Front Immunol. 2024. PMID: 39224588 Free PMC article. Review. - Conditional RNA interference in mammalian cells via RNA transactivation.
Zhou Y, Sheng P, Li J, Li Y, Xie M, Green AA. Zhou Y, et al. Nat Commun. 2024 Aug 10;15(1):6855. doi: 10.1038/s41467-024-50600-w. Nat Commun. 2024. PMID: 39127751 Free PMC article. - Engineering a targeted and safe bone anabolic gene therapy to treat osteoporosis in alveolar bone loss.
Lin C, Yang YS, Ma H, Chen Z, Chen D, John AA, Xie J, Gao G, Shim JH. Lin C, et al. Mol Ther. 2024 Sep 4;32(9):3080-3100. doi: 10.1016/j.ymthe.2024.06.036. Epub 2024 Jun 26. Mol Ther. 2024. PMID: 38937970
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources